Intravenous basic fibroblast growth factor decrease brain injury resulting from focal ischemia in cats

Ameil Bethel, Jeffrey R. Kirsch, Raymond C Koehler, Seth P. Finklestein, Richard J. Traystman

Research output: Contribution to journalArticle

Abstract

Background and Purpose: We tested the hypothesis that intravenous administration of basic fibroblast growth factor (bFGF) during 4 hours of permanent focal ischemia would affect acute brain injury. Methods: Halothane- anesthetized cats underwent left middle cerebral artery (MCA) occlusion for 4 hours. Control cats received diluent (n = 14). Experimental cats were treated with bFGF at a rate of 5 (n = 13), 50 (n = 13), or 250 μg/kg per hour (n = 9) intravenously beginning 60 minutes after initiation of ischemia and continuing until the end of the protocol. Results: As measured by the microsphere method, blood flow to ipsilateral caudate nucleus and ipsilateral inferior temporal cortex was decreased similarly during ischemia, before drug administration, in all groups. Likewise, there was no difference in blood flow to ipsilateral caudate nucleus or inferior temporal cortex as a result of bFGF administration during MCA occlusion. Triphenyltetrazolium-determined injury volume of the ipsilateral cerebral cortex (control, 40 ± 7%; bFGF 5 μg/kg per hour, 22 ± 5%; bFGF 50 μg/kg per hour, 26 ± 7%; bFGF 255 μg/kg per hour, 23 ± 6% of ipsilateral cerebral cortex; mean ± SEM) was less in cats treated with bFGF. There was no difference among groups in injury volume to caudate nucleus (control, 29 ± 8%; bFGF 5 μg/kg per hour, 29 ± 8%; bFGF 50 μg/kg per hour, 21 ± 7%; bFGF 250 μg/kg per hour, 32 ± 7% of ipsilateral caudate nucleus). Somatosensory evoked potential amplitude decreased similarly (to

Original languageEnglish (US)
Pages (from-to)609-616
Number of pages8
JournalStroke
Volume28
Issue number3
StatePublished - Mar 1997

Fingerprint

Fibroblast Growth Factor 2
Brain Injuries
Cats
Ischemia
Caudate Nucleus
Fibroblast Growth Factor 5
Middle Cerebral Artery Infarction
Temporal Lobe
Cerebral Cortex
Fibroblast Growth Factor 4
Somatosensory Evoked Potentials
Wounds and Injuries
Halothane
Microspheres
Intravenous Administration

Keywords

  • cats
  • cerebral blood flow
  • growth factors
  • middle cerebral artery occlusion
  • neuroprotection
  • somatosensory evoked potentials

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuroscience(all)

Cite this

Bethel, A., Kirsch, J. R., Koehler, R. C., Finklestein, S. P., & Traystman, R. J. (1997). Intravenous basic fibroblast growth factor decrease brain injury resulting from focal ischemia in cats. Stroke, 28(3), 609-616.

Intravenous basic fibroblast growth factor decrease brain injury resulting from focal ischemia in cats. / Bethel, Ameil; Kirsch, Jeffrey R.; Koehler, Raymond C; Finklestein, Seth P.; Traystman, Richard J.

In: Stroke, Vol. 28, No. 3, 03.1997, p. 609-616.

Research output: Contribution to journalArticle

Bethel, A, Kirsch, JR, Koehler, RC, Finklestein, SP & Traystman, RJ 1997, 'Intravenous basic fibroblast growth factor decrease brain injury resulting from focal ischemia in cats', Stroke, vol. 28, no. 3, pp. 609-616.
Bethel, Ameil ; Kirsch, Jeffrey R. ; Koehler, Raymond C ; Finklestein, Seth P. ; Traystman, Richard J. / Intravenous basic fibroblast growth factor decrease brain injury resulting from focal ischemia in cats. In: Stroke. 1997 ; Vol. 28, No. 3. pp. 609-616.
@article{0c966ce61ac147e8ae6cfe948518707c,
title = "Intravenous basic fibroblast growth factor decrease brain injury resulting from focal ischemia in cats",
abstract = "Background and Purpose: We tested the hypothesis that intravenous administration of basic fibroblast growth factor (bFGF) during 4 hours of permanent focal ischemia would affect acute brain injury. Methods: Halothane- anesthetized cats underwent left middle cerebral artery (MCA) occlusion for 4 hours. Control cats received diluent (n = 14). Experimental cats were treated with bFGF at a rate of 5 (n = 13), 50 (n = 13), or 250 μg/kg per hour (n = 9) intravenously beginning 60 minutes after initiation of ischemia and continuing until the end of the protocol. Results: As measured by the microsphere method, blood flow to ipsilateral caudate nucleus and ipsilateral inferior temporal cortex was decreased similarly during ischemia, before drug administration, in all groups. Likewise, there was no difference in blood flow to ipsilateral caudate nucleus or inferior temporal cortex as a result of bFGF administration during MCA occlusion. Triphenyltetrazolium-determined injury volume of the ipsilateral cerebral cortex (control, 40 ± 7{\%}; bFGF 5 μg/kg per hour, 22 ± 5{\%}; bFGF 50 μg/kg per hour, 26 ± 7{\%}; bFGF 255 μg/kg per hour, 23 ± 6{\%} of ipsilateral cerebral cortex; mean ± SEM) was less in cats treated with bFGF. There was no difference among groups in injury volume to caudate nucleus (control, 29 ± 8{\%}; bFGF 5 μg/kg per hour, 29 ± 8{\%}; bFGF 50 μg/kg per hour, 21 ± 7{\%}; bFGF 250 μg/kg per hour, 32 ± 7{\%} of ipsilateral caudate nucleus). Somatosensory evoked potential amplitude decreased similarly (to",
keywords = "cats, cerebral blood flow, growth factors, middle cerebral artery occlusion, neuroprotection, somatosensory evoked potentials",
author = "Ameil Bethel and Kirsch, {Jeffrey R.} and Koehler, {Raymond C} and Finklestein, {Seth P.} and Traystman, {Richard J.}",
year = "1997",
month = "3",
language = "English (US)",
volume = "28",
pages = "609--616",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Intravenous basic fibroblast growth factor decrease brain injury resulting from focal ischemia in cats

AU - Bethel, Ameil

AU - Kirsch, Jeffrey R.

AU - Koehler, Raymond C

AU - Finklestein, Seth P.

AU - Traystman, Richard J.

PY - 1997/3

Y1 - 1997/3

N2 - Background and Purpose: We tested the hypothesis that intravenous administration of basic fibroblast growth factor (bFGF) during 4 hours of permanent focal ischemia would affect acute brain injury. Methods: Halothane- anesthetized cats underwent left middle cerebral artery (MCA) occlusion for 4 hours. Control cats received diluent (n = 14). Experimental cats were treated with bFGF at a rate of 5 (n = 13), 50 (n = 13), or 250 μg/kg per hour (n = 9) intravenously beginning 60 minutes after initiation of ischemia and continuing until the end of the protocol. Results: As measured by the microsphere method, blood flow to ipsilateral caudate nucleus and ipsilateral inferior temporal cortex was decreased similarly during ischemia, before drug administration, in all groups. Likewise, there was no difference in blood flow to ipsilateral caudate nucleus or inferior temporal cortex as a result of bFGF administration during MCA occlusion. Triphenyltetrazolium-determined injury volume of the ipsilateral cerebral cortex (control, 40 ± 7%; bFGF 5 μg/kg per hour, 22 ± 5%; bFGF 50 μg/kg per hour, 26 ± 7%; bFGF 255 μg/kg per hour, 23 ± 6% of ipsilateral cerebral cortex; mean ± SEM) was less in cats treated with bFGF. There was no difference among groups in injury volume to caudate nucleus (control, 29 ± 8%; bFGF 5 μg/kg per hour, 29 ± 8%; bFGF 50 μg/kg per hour, 21 ± 7%; bFGF 250 μg/kg per hour, 32 ± 7% of ipsilateral caudate nucleus). Somatosensory evoked potential amplitude decreased similarly (to

AB - Background and Purpose: We tested the hypothesis that intravenous administration of basic fibroblast growth factor (bFGF) during 4 hours of permanent focal ischemia would affect acute brain injury. Methods: Halothane- anesthetized cats underwent left middle cerebral artery (MCA) occlusion for 4 hours. Control cats received diluent (n = 14). Experimental cats were treated with bFGF at a rate of 5 (n = 13), 50 (n = 13), or 250 μg/kg per hour (n = 9) intravenously beginning 60 minutes after initiation of ischemia and continuing until the end of the protocol. Results: As measured by the microsphere method, blood flow to ipsilateral caudate nucleus and ipsilateral inferior temporal cortex was decreased similarly during ischemia, before drug administration, in all groups. Likewise, there was no difference in blood flow to ipsilateral caudate nucleus or inferior temporal cortex as a result of bFGF administration during MCA occlusion. Triphenyltetrazolium-determined injury volume of the ipsilateral cerebral cortex (control, 40 ± 7%; bFGF 5 μg/kg per hour, 22 ± 5%; bFGF 50 μg/kg per hour, 26 ± 7%; bFGF 255 μg/kg per hour, 23 ± 6% of ipsilateral cerebral cortex; mean ± SEM) was less in cats treated with bFGF. There was no difference among groups in injury volume to caudate nucleus (control, 29 ± 8%; bFGF 5 μg/kg per hour, 29 ± 8%; bFGF 50 μg/kg per hour, 21 ± 7%; bFGF 250 μg/kg per hour, 32 ± 7% of ipsilateral caudate nucleus). Somatosensory evoked potential amplitude decreased similarly (to

KW - cats

KW - cerebral blood flow

KW - growth factors

KW - middle cerebral artery occlusion

KW - neuroprotection

KW - somatosensory evoked potentials

UR - http://www.scopus.com/inward/record.url?scp=0030932239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030932239&partnerID=8YFLogxK

M3 - Article

C2 - 9056620

AN - SCOPUS:0030932239

VL - 28

SP - 609

EP - 616

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 3

ER -